(Video) GlaxoSmithKline plc Gives Up On Cancer

Why would GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), one of the world’s largest pharmaceutical companies, want to get out of the business of treating cancer? Following its deal with Novartis, that’s exactly what it has done… in this video, Owain Bennallack explains why he thinks it is a strong move.

GlaxoSmithKline is one of five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On". To find out the reasons behind their inclusion, and the names of the other four shares, simply click here to have it delivered competely free to your inbox.

Owain owns shares in GSK. The Motley Fool has recommended shares in GlaxoSmithKline.